The Neuroprotective Effect of Increased PINK1 Expression Following Glutamate Excitotoxicity in Neuronal Cells

Neuroscience. 2022 Jan 1:480:97-107. doi: 10.1016/j.neuroscience.2021.11.020. Epub 2021 Nov 17.

Abstract

Ischemic injury in patients with stroke often leads to neuronal damage and mitochondrial dysfunction. Neuronal injury caused by ischemia can be partly attributed to glutamate (L-Glu) excitotoxicity. Previous studies have shown that PTEN-induced kinase 1 (PINK1) plays a neuroprotective role in ischemic brain injury by regulating mitochondrial integrity and function. However, there are few reports on the expression of PINK1 in L-Glu excitotoxicity models, its effect on neuronal survival, and whether PINK1 plays a protective role in stroke by regulating mitophagy. In the present study, different concentrations of L-Glu inhibited the viability of neurons. After L-Glu treatment at different times, the mRNA level, protein level, and cellular fluorescence intensity of PINK1 first increased and then decreased. Compared with normal cells, cells with low PINK1 expression enhanced the inhibitory effect of L-Glu on neuronal activity, while those with high PINK1 expression showed a protective effect on neurons by alleviating mitochondrial membrane potential loss. In addition, RAP (an autophagy activator) could increase the co-localization of the mitophagy-related proteins light chain 3 (LC3) and Tom20, whereas 3-MA (an autophagy inhibitor) exerted the opposite effect. Finally, we found that L-Glu could induce the expression of PINK1/Parkin/ LC3 in neurons at both mRNA and protein levels, while RAP could further increase their expression, and 3-MA decreased their expression. Taken together, PINK1 protects against L-Glu-induced neuronal injury by protecting mitochondrial function, and the potential protective mechanism may be closely related to the enhancement of mitophagy mediated by the PINK1/Parkin signaling pathway.

Keywords: LC3; PINK1; Parkin; glutamate excitotoxicity; ischemic stroke; mitophagy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glutamic Acid / toxicity
  • Humans
  • Mitophagy
  • Neurons
  • Neuroprotective Agents* / pharmacology
  • Protein Kinases / pharmacology
  • Ubiquitin-Protein Ligases

Substances

  • Neuroprotective Agents
  • Glutamic Acid
  • Ubiquitin-Protein Ligases
  • Protein Kinases